# Modelling the ageing gastrointestinal system in-vitro using whey protein isolate

**Authors:** Laura Gunning, Michael O'Sullivan, Eugene Dillon, Raquel Cama-Moncunill, Jean-Christophe Jacquier

PMC · DOI: 10.1016/j.fochx.2026.103671 · Food Chemistry: X · 2026-02-17

## TL;DR

This study adapts digestion models to simulate how aging affects protein breakdown in older adults, showing reduced digestion efficiency.

## Contribution

The study introduces an in-vitro model tailored to older adults' gastrointestinal conditions, revealing unique digestion patterns.

## Key findings

- Older adult gastric conditions led to more protein aggregates and intact proteins.
- Intestinal digestion showed smaller differences but distinct proteolytic profiles.
- Antimicrobial peptides increased significantly in intestinal digesta of older adults.

## Abstract

The aims of this study were to adapt current in-vitro digestion protocols to replicate older adults suffering from gastrointestinal infections or those on polypharmacy. The whey protein breakdown was characterised within simulated gastric and intestinal phases, by measuring degree of hydrolysis, bio-accessible peptides, molecular weight distribution by Size Exclusion Chromatography, as well as peptide sequencing using High Resolution LC-MS. Differences due to older adult digestive conditions significantly affected the digestion of whey protein, seen by the presence of some aggregates and intact proteins, and less bio accessible peptides at the end of the gastric phase. These differences were also seen in the intestinal digesta, albeit to a lesser extent wheredistinct proteolytic profiles were seen. This study shows the importance of adapting the simulated gastrointestinal conditions to better represent the ageing gastrointestinal systems of our elderly population, and to better understand the poor protein assimilation by this ageing cohort.

•Current in-vitro digestion protocols adapted to older adults suffering from gastrointestinal infections or those on polypharmacy.•Elderly gastric conditions affected whey protein breakdown with increased presence of large aggregates and intact proteins.•Smaller differences seen in intestinal digesta.•Antimicrobial peptides found to significantly increase in intestinal digesta of older adult SGID.

Current in-vitro digestion protocols adapted to older adults suffering from gastrointestinal infections or those on polypharmacy.

Elderly gastric conditions affected whey protein breakdown with increased presence of large aggregates and intact proteins.

Smaller differences seen in intestinal digesta.

Antimicrobial peptides found to significantly increase in intestinal digesta of older adult SGID.

## Full-text entities

- **Genes:** LALBA (lactalbumin alpha) [NCBI Gene 281894] {aka a-LACTA, alfaLA}, PTI (pancreatic trypsin inhibitor) [NCBI Gene 404172] {aka BPI, BPTI}, PAEP (progestagen-associated endometrial protein) [NCBI Gene 280838] {aka BLG, LGB}, GIP (gastric inhibitory polypeptide) [NCBI Gene 511073], P4HB (prolyl 4-hydroxylase subunit beta) [NCBI Gene 281373] {aka PDI}, LALBA (lactalbumin alpha) [NCBI Gene 3906] {aka HAMLET, LYZG}, DPP4 (dipeptidyl peptidase 4) [NCBI Gene 281122] {aka ACT3, ADCP-I, CD26, DPPIV, WC10}, ALB (albumin) [NCBI Gene 280717]
- **Diseases:** sarcopenia (MESH:D055948), OA2 (MESH:C536013), hypochlorhydria (MESH:D000126), muscle turnover (MESH:D019042), H. pylori infection (MESH:D016481), OA (MESH:D010003), frailty (MESH:D000073496), OA3 (MESH:C567098), SGID (MESH:D004828), stroke (MESH:D020521), gastrointestinal conditions (MESH:D005767), cardiovascular conditions (MESH:D002318), GI infections (MESH:D007239), digestive-system related diseases (MESH:D004066), osteoporosis (MESH:D010024), high blood pressure (MESH:D006973), gastro-intestinal infections (MESH:D007410), Gastric (MESH:D013272), type-2 diabetes (MESH:D003924), heart disease (MESH:D006331)
- **Chemicals:** polymers (MESH:D011108), Acetonitrile (MESH:C032159), NaCl (MESH:D012965), HCl (MESH:D006851), SDS (MESH:D012967), dithiothreitol (MESH:D004229), BCAAs (MESH:D000597), NaOH (MESH:D012972), cholesterol (MESH:D002784), ethanol (MESH:D000431), Water (MESH:D014867), Leucine (MESH:D007930), (NH4)2CO3 (MESH:C040502), peptide (MESH:D010455), AA (MESH:D000596), TFA (MESH:D014269), l-Serine (MESH:D012694), Phenylalanine (MESH:D010649), TCA (MESH:D014238), bile salts (MESH:D001647), NaHCO3 (MESH:D017693), MgCl2(H2O)6 (-), OPA (MESH:D009764), Tryptophan (MESH:D014364), KCl (MESH:D011189), Mn (MESH:D008345), polystyrene (MESH:D011137)
- **Species:** Helicobacter pylori (species) [taxon 210], Homo sapiens (human, species) [taxon 9606], Powellomyces sp. EA (species) [taxon 252690], Bos taurus (bovine, species) [taxon 9913], Oryza sativa (Asian cultivated rice, species) [taxon 4530]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936768/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936768/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936768/full.md

---
Source: https://tomesphere.com/paper/PMC12936768